Impact of Intravenous Loop Diuretics on Outcomes of Patients Hospitalized with Acute Decompensated Heart Failure: Insights from the ADHERE RegistryW. Franklin Peacock, Charles L. Emerman, Janet Wynne et al.|Cardiology|2008Cited by 263
Timing of Immunoreactive B-Type Natriuretic Peptide Levels and Treatment Delay in Acute Decompensated Heart FailureAlan S. Maisel, Roger M. Mills, Robert Jessie et al.|Journal of the American College of Cardiology|2008Cited by 206
Characteristics of “Stage D” heart failure: Insights from the Acute Decompensated Heart Failure National Registry Longitudinal Module (ADHERE LM)Maria Rosa Costanzo, Janet Wynne, Roger M. Mills|American Heart Journal|2007Cited by 146
Impact of Early Initiation of Intravenous Therapy for Acute Decompensated Heart Failure on Outcomes in ADHEREW. Frank Peacock, Janet Wynne, Gregg C. Fonarow et al.|Cardiology|2006Cited by 116
Illicit Stimulant Use in a United States Heart Failure Population Presenting to the Emergency Department (from the Acute Decompensated Heart Failure National Registry Emergency Module)Deborah B. Diercks, W. Franklin Peacock, Roger M. Mills et al.|The American Journal of Cardiology|2008Cited by 72